The Iron Peak Pharmaceutical 2025 Work Conference was grandly held.


Classification:

Corporate News

Author:

Source:

Release time:

2025-02-12

summary: On January 26, the 2025 work conference of Tiefeng Pharmaceutical was grandly held in Yunnan Huadu, Kunming. More than 60 leaders, key personnel, and employee representatives from Yunnan Tiefeng, Yunnan Haoran, and Xichang Jinfeng attended the meeting to jointly review the struggles of 2024 and plan new development paths for 2025.

The grand opening of the Tie Feng Pharmaceutical 2025 Work Conference

 

On January 26, the Tie Feng Pharmaceutical 2025 Work Conference was grandly held in Kunming City, Yunnan Province. More than 60 leaders, key personnel, and employee representatives from Yunnan Tie Feng, Yunnan Haoran, and Xichang Jinfeng attended the meeting to review the struggles of 2024 and plan new development paths for 2025.

The conference comprehensively summarized the achievements made by the company in various fields such as production, sales, safety and environmental protection, technological research and development, and technical services over the past year. It recognized the "advanced collectives" and "advanced individuals" for the 2024 work, planned and deployed the main goals and key tasks for 2025, and proposed a new high-quality development goal of "1523111" for 2025 based on the 2024 "132311" target, signing the responsibility letter for the production and operation goals of 2025.

Figure (1)

The year 2024 is a milestone year in the development history of Tie Feng Pharmaceutical. Against the backdrop of significant domestic and international changes and the intense competition in the market, the company's leadership team led all employees to face challenges head-on, seize market opportunities, adhere to technological innovation, and follow the development path of "one mine, one medicine." Production was safely and stably operated, with output breaking historical records, achieving a good situation of both production and sales flourishing. The "one mine, one medicine" research and development yielded fruitful results, safety management levels steadily improved, equipment updates and technological reforms were carried out in an orderly manner, on-site environments significantly improved, the construction of the R&D building was in full swing, and new project construction made phased progress.

 

Figure (2)

  

Figure (3)

Figure (4)

Figure (5)

After listening to the annual work reports from the leadership team members, Chairman Zhu Yuanbin made an in-depth summary and delivered an important speech. He emphasized that the "1523111" goal is an important strategic decision for Tie Feng to enter the international market and achieve a second leap. He pointed out that management cadres should be brave enough to break traditional thinking, dare to take on heavy responsibilities, and actively pursue self-reform; they should focus on creating an innovative atmosphere, encourage employees to innovate boldly, optimize the talent team structure, and build a passionate and combat-effective "Iron Army."

Figure (6)

In terms of talent development, Chairman Zhu Yuanbin proposed to establish a sound mechanism for selecting, employing, training, and retaining talent, vigorously introducing high-end talents in fields such as technological research and development, market marketing, and business management. Using employee stock ownership and other incentive mechanisms as a starting point, a strong atmosphere for entrepreneurship should be created. At the same time, all employees are required to integrate the five-segment management work method into their daily work to continuously improve work quality and efficiency. He emphasized that the entire company should form a strong cohesion and centripetal force, unify thoughts and actions, strengthen development beliefs, and work together to promote the company's high-quality development. Let the business philosophy of "one mine, one medicine" create value for customers around the world, and let the "Jinfengda" brand of flotation agents shine on the world mining stage, helping Tie Feng successfully land on the Beijing Stock Exchange and achieve the grand goal of creating a world-class flotation agent enterprise.

Figure (7)

Looking ahead to 2025, Tie Feng Pharmaceutical will take the brilliant achievements of 2024 as a cornerstone, refine and decompose the "1523111" goal, strictly follow the five-segment management work method, and solidly promote production and operation, technological research and development, new project construction, and listing preparations. With a united front and determination, we will write a new chapter of high-quality development!